National Health Commission calls for production of generic drugs
The National Health Commission on Thursday released a list of 34 patented drugs and encouraged the production of generic alternatives.
The drugs were selected from a variety used in China whose patents have expired or will soon expire, drugs that are in short supply and drugs whose manufacturers voluntarily applied, the commission said.
The list, which includes drugs that treat serious diseases such as AIDS and leukemia, was published on the commission's website and is soliciting public opinion for five working days.
A plan released by 12 central government departments, including the commission, earlier said the first list of recommended drugs should be released before the end of June to guide pharmaceutical companies' research, development and production.
Such a list will be released every year, the plan said.
A State Council guideline released last year said authorities should take measures to encourage the research and development of generic drugs that are badly in need, to meet the needs of patients and reduce their drug expenditures.
- Chongqing sets GDP growth target of over 5% for 2026
- Xinjiang strengthens economic, cultural ties with Hong Kong, Macao
- Former senior political adviser sentenced to 12 years for bribery
- Hubei's government becomes first in China to add 'emotional value' to work report
- Foshan eyes new steps to enhance its manufacturing and trade prowess
- Foshan Station marks a milestone as it moves toward construction
